Bayer Aktiengesellschaft (BAYN.DE)
XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
At close: 05:39PM CEST
| Previous close | 26.90 |
| Open | 27.05 |
| Bid | 27.50 x 28400 |
| Ask | 27.50 x 2100 |
| Day's range | 26.97 - 27.58 |
| 52-week range | 24.96 - 60.15 |
| Volume | |
| Avg. volume | 4,773,188 |
| Market cap | 26.918B |
| Beta (5Y monthly) | 0.97 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.99 |
| Earnings date | 14 May 2024 |
| Forward dividend & yield | 0.11 (0.41%) |
| Ex-dividend date | 29 Apr 2024 |
| 1y target est | 34.80 |
ZacksRoche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Roche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue to decline. The top line suffers due to the appreciation of the Swiss franc against most currencies.
FortunePharmaceutical giant Bayer’s manager cull will likely affect thousands of bosses—and the aspirin inventor thinks it will help its ‘brilliant’ Gen Z grads to thrive
Bayer currently has more than twelve tiers between management and its customers in some departments, and the aim of CEO Bill Anderson is to reduce that to around five or six.
FortunePharmaceutical giant Bayer is getting rid of bosses and asking nearly 100,000 workers to ‘self-organize’ to save $2.15 billion
Chief executive Bill Anderson says he doesn’t want it to be a "lame" company, but its stock has still tanked 50%.
© 2024 Yahoo. All rights reserved.